What is the price of Aroa Biosurgery Limited (ARX)

The price of Aroa Biosurgery Limited (ARX) is $0.39848591

What is the market cap of Aroa Biosurgery Limited (ARX)

The market cap of Aroa Biosurgery Limited (ARX) is $137.67M

Aroa Biosurgery Limited (ARX) P/B Ratio

Aroa Biosurgery Limited operates as a regenerative medicine company dedicated to the development, production, and global distribution of medical solutions for wound and tissue repair. The firm innovatively utilizes extracellular matrix (ECM) technology, with its market presence spanning the United States and international territories. Its product line encompasses Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold, tailored for managing both acute and chronic wounds. Additionally, the company offers Myriad Matrix, an engineered ECM device designed for soft tissue repair, reinforcement, and complex wound treatment, along with Myriad Morcells, a powdered version of Myriad Matrix serving similar soft tissue and complex wound applications. Rounding out its offerings are Reinforced Bioscaffolds, a specialized surgical product employed in ventral hernia repair and abdominal wall reconstruction. Founded in 2007, Aroa Biosurgery Limited is headquartered in Auckland, New Zealand.

Year	P/B Ratio	Change
Not enough data for the provided dates.

Year

P/B Ratio

Change

Not enough data for the provided dates.

Company	P/B Ratio	P/B Ratio Difference	Country
Abbott Laboratories ABT.US	3.7944	-	US
Stryker Corporation SYK.US	5.423	-	US
Medtronic plc MDT.US	2.0146	-	IE
Boston Scientific Corporation BSX.US	3.072	-	US
Siemens Healthineers AG SHL.DE	-	-	DE

Company

P/B Ratio

P/B Ratio Difference

Country